CME Innovation Obesity 
Cardiometabolic Health Congress
NOVEMBER 14, 2024
cardiometabolic health CME/CE conference: the 19th Annual CMHC. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. 4 Advances in Obesity Pharmacotherapy Session: “Advances in Obesity Pharmacotherapy” Presenter: Louis J. In the U.S.,
Cardiometabolic Health Congress
OCTOBER 25, 2024
The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations.
Cardiometabolic Health Congress
AUGUST 14, 2024
This October, we gather for the largest and most innovative cardiometabolic event, honoring Dr. Bakris’ profound impact on our community. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. To apply, click here or go to www.cardiometabolichealth.org/george-bakris-scholarship-program/ NEW! Chair: Erin D.
Cardiometabolic Health Congress
JULY 25, 2024
This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Innovations in Cardiorenal Metabolic Medicine The event will focus on the whole spectrum of cardiorenal metabolic disease, including obesity, diabetes, lipids, hypertension, and cardiorenal disease.
Cardiometabolic Health Congress
DECEMBER 5, 2024
As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. SUMMIT Trial : Weekly subcutaneous tirzepatide showed significant reductions in CV death and HF-related events among patients with HFpEF and obesity. View the study.
Expert insights. Personalized for you.
103 
Let's personalize your content